Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation

Abstract

ILT3 is a highly sensitive and specific marker which distinguishes AML with monocytic differentiation from other types of AML. Testing of ILT3 expression should be incorporated into the initial diagnostic work-up and monitoring of patients with AML.